Fingerprint Dive into the research topics of 'Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
Marco Gallo, Pasqualino Malandrino, Giuseppe Fanciulli, Francesca Rota, Antongiulio Faggiano, Annamaria Colao, NIKE Group, Roberto Buzzoni, Jorgelina Coppa, Massimo Milione, Sara Pusceddu
Research output: Contribution to journal › Review article › peer-review